These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 4055162

  • 1. Pharmacokinetics of norfloxacin in chronic renal failure.
    Arrigo G, Cavaliere G, D'Amico G, Passarella E, Broccali G.
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):491-6. PubMed ID: 4055162
    [Abstract] [Full Text] [Related]

  • 2. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA, Hak LJ, Coakley DF, Falk RJ, Wagner BE, Raasch RH, van der Horst CM, Kaul S, Barbhaiya RH, Dukes GE.
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [Abstract] [Full Text] [Related]

  • 3. Amantadine hydrochloride pharmacokinetics in patients with impaired renal function.
    Wu MJ, Ing TS, Soung LS, Daugirdas JT, Hano JE, Gandhi VC.
    Clin Nephrol; 1982 Jan; 17(1):19-23. PubMed ID: 7035042
    [Abstract] [Full Text] [Related]

  • 4. Doses of antibiotic in patients with renal insufficiency.
    Ohkawa M, Kuroda K.
    Clin Ther; 1981 Jan; 4 Suppl A():124-32. PubMed ID: 6275994
    [Abstract] [Full Text] [Related]

  • 5. The kinetics of aminosidine in renal patients with different degrees of renal failure.
    Novarini A, Montanari A, Bruschi G, Rossi E, Borghetti A, Migone L.
    Clin Nephrol; 1975 Jul; 4(1):23-4. PubMed ID: 1157346
    [Abstract] [Full Text] [Related]

  • 6. Butofilolol pharmacokinetics in chronic renal insufficiency.
    Jeanniot JP, Houin G, Ledudal P, Cautreels W, Giudicelli CP, Tillement JP.
    Int J Clin Pharmacol Res; 1984 Jul; 4(3):165-73. PubMed ID: 6149194
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of ceftriaxone in subjects with renal insufficiency.
    Kowalsky SF, Echols RM, Parker MA.
    Clin Pharm; 1985 Jul; 4(2):177-81. PubMed ID: 3987216
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP, Ings RM, Leroy A, Humbert G, Godin M.
    Nouv Presse Med; 1981 Feb 26; 10(8):574-9. PubMed ID: 6259595
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of ofloxacin in severe chronic renal failure.
    Bandai H, Tsubakihara Y, Yamato E, Yokoyama K, Okada N, Nakanishi I, Iida N.
    Clin Ther; 1989 Feb 26; 11(2):210-8. PubMed ID: 2736567
    [Abstract] [Full Text] [Related]

  • 10. Serum levels and half-life of sotalol in chronic renal failure.
    Sundquist HK, Anttila M, Forsström J, Kasanen A.
    Ann Clin Res; 1975 Dec 26; 7(6):442-6. PubMed ID: 1211858
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of teicoplanin in burn patients.
    Potel G, Moutet J, Bernareggi A, Le Normand Y, Meigner M, Baron D.
    Scand J Infect Dis Suppl; 1990 Dec 26; 72():29-34. PubMed ID: 2151064
    [Abstract] [Full Text] [Related]

  • 12. Disposition kinetics of dibekacin in normal subjects and in patients with renal failure.
    Arancibia A, Chávez J, Ibarra R, Ruiz I, Icarte A, Thambo S, Chávez H.
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan 26; 25(1):38-43. PubMed ID: 3557728
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of anakinra in subjects with different levels of renal function.
    Yang BB, Baughman S, Sullivan JT.
    Clin Pharmacol Ther; 2003 Jul 26; 74(1):85-94. PubMed ID: 12844139
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of cicletanine in patients with impaired renal function.
    Jungers P.
    Drugs Exp Clin Res; 1988 Jul 26; 14(2-3):189-94. PubMed ID: 3416723
    [Abstract] [Full Text] [Related]

  • 15. A study of practolol elimination in all grades of chronic renal failure.
    Kaye CM, Kumana CR, Franklin DA, Baker LR.
    Int J Clin Pharmacol Biopharm; 1975 Jul 26; 12(1-2):83-8. PubMed ID: 1165145
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.
    Chen N, Lau H, Kong L, Kumar G, Zeldis JB, Knight R, Laskin OL.
    J Clin Pharmacol; 2007 Dec 26; 47(12):1466-75. PubMed ID: 17954615
    [Abstract] [Full Text] [Related]

  • 17. Gentamicin disposition in children with chronic renal failure.
    Berry PL, Kearns GL, Brown RD, Ritschel WA, Thompson GA, McEnery PT.
    Pediatr Pharmacol (New York); 1982 Dec 26; 2(4):257-73. PubMed ID: 6927126
    [Abstract] [Full Text] [Related]

  • 18. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S, Orlando R, Bertoli M, Pegoraro P, Palatini P.
    Clin Pharmacol Ther; 2006 Dec 26; 80(6):597-606. PubMed ID: 17178261
    [Abstract] [Full Text] [Related]

  • 19. Alprazolam kinetics in patients with renal insufficiency.
    Ochs HR, Greenblatt DJ, Labedzki L, Smith RB.
    J Clin Psychopharmacol; 1986 Oct 26; 6(5):292-4. PubMed ID: 3771810
    [Abstract] [Full Text] [Related]

  • 20. [Pharmacokinetics of intramuscular mezlocillin in patients with normal and impaired renal function (author's transl)].
    Brogard JM, Comte F, Kopferschmitt J, Dorner M, Lavillaureix.
    Nouv Presse Med; 1982 Feb 04; 11(5 Pt 2):340-6. PubMed ID: 6460973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.